Liver transplantation (LT) is an established therapy for patients with end-stage primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). In this report, we describe the health status and quality of life (QOL) in patients with these cholestatic liver diseases before and after LT. A Q
Liver transplantation for cholestatic liver disease
β Scribed by James Neuberger
- Book ID
- 107556295
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 339 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1092-8472
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mayo risk score, United Network for Organ Sharing (UNOS) status, Organ Sharing.
Hepatic sarcoidosis is a rare indication for liver transplantation. Using the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) database, we evaluated patient and graft survival after orthotopic liver transplantation for sarcoidosis between October 1987 and
Polycystic liver disease, commonly associated with polycystic kidney disease, can result in massive hepatomegaly and debilitating symptoms. Surgical intervention for symptomatic polycystic liver disease has been associated with significant morbidity and inconsistent long-term palliation; it is more